Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment

References

• Bagan J, Sarrion G, Jimenez Y. Oral cancer: clinical features. Oral Oncol. 2010;46:414–417. doi:10.1016/j.oraloncology.2010.03.009
   PubMed Web of Science ®Google Scholar
• Shield KD, Ferlay J, Jemal A, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67:51–64. doi:10.3322/caac.21384
   PubMed Web of Science ®Google Scholar
• Rengaswamy Sankaranarayanan KR, Amarasinghe H, Subramanian S, Johnson N. Cancer. editors, Gelband H, Jha P, Sankaranarayanan R, Horton S. In: Disease Control Priorities. Third ed. Vol. 3. The International Bank for Reconstruction and Development; 2015.
   Google Scholar
• Liang D, Xiao-Feng H, Guan-Jun D, et al. Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun/CCL22 signal. Biochim Biophys Acta. 2015;1852:2494–2503. doi:10.1016/j.bbadis.2015.08.011
   PubMed Web of Science ®Google Scholar
• Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884–11894.
   PubMed Web of Science ®Google Scholar
• Su CC, Lee K-I, Chen M-K, et al. Cantharidin induced oral squamous cell carcinoma cell apoptosis via the JNK-regulated mitochondria and endoplasmic reticulum stress-related signaling pathways. PLoS One. 2016;11:e0168095. doi:10.1371/journal.pone.0168095
   PubMed Web of Science ®Google Scholar
• Vyhnalova T, Danek Z, Gachova D, Linhartova PB. The role of the oral microbiota in the etiopathogenesis of oral squamous cell carcinoma. Microorganisms. 2021;9:1549. doi:10.3390/microorganisms9081549
   PubMed Web of Science ®Google Scholar
• Jawert F, Nyman J, Olsson E, et al. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer. Oral Oncol. 2021;121:105469. doi:10.1016/j.oraloncology.2021.105469
   PubMed Web of Science ®Google Scholar
• Liao CT, Chen H-N, Wen Y-W, et al. Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma. Eur J Cancer. 2017;72:226–234. doi:10.1016/j.ejca.2016.11.010
   PubMed Web of Science ®Google Scholar
• Bavle RM, Venugopal R, Konda P, Muniswamappa S, Makarla S. Molecular classification of oral squamous cell carcinoma. JCDR. 2016;10:Ze18–ze21. doi:10.7860/jcdr/2016/19967.8565
   PubMedGoogle Scholar
• Brocklehurst PR, Baker SR, Speight PM. Oral cancer screening: what have we learnt and what is there still to achieve? Future Oncol. 2010;6:299–304. doi:10.2217/fon.09.163
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–386. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Ng JH, Iyer NG, Tan MH, Edgren G. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39:297–304. doi:10.1002/hed.24589
   PubMed Web of Science ®Google Scholar
• Sun X, Li P, Zhang M, Ma W. Research progress of exosomes in oral cancer. J Chin Oncol. 2020. doi:10.11735/j.issn.1671-170X.2020.06.B004
   Web of Science ®Google Scholar
• Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27:172–188. doi:10.1016/j.tcb.2016.11.003
   PubMed Web of Science ®Google Scholar
• Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protocols Cell Biol. 2006;3:Unit 3.22. doi:10.1002/0471143030.cb0322s30
   Google Scholar
• Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998;4:594–600. doi:10.1038/nm0598-594
   PubMed Web of Science ®Google Scholar
• Peters PJ, Geuze HJ, Van Donk HAD, et al. Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur J Immunol. 1989;19:1469–1475. doi:10.1002/eji.1830190819
   PubMed Web of Science ®Google Scholar
• Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161–1172. doi:10.1084/jem.183.3.1161
   PubMed Web of Science ®Google Scholar
• Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7:297–303. doi:10.1038/85438
   PubMed Web of Science ®Google Scholar
• Faure J, Lachenal G, Court M, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci. 2006;31:642–648. doi:10.1016/j.mcn.2005.12.003
   PubMed Web of Science ®Google Scholar
• Chung IM, Rajakumar G, Venkidasamy B, Subramanian U, Thiruvengadam M. Exosomes: current use and future applications. Clin Chim Acta. 2020;500:226–232. doi:10.1016/j.cca.2019.10.022
   PubMed Web of Science ®Google Scholar
• Khushman M, Bhardwaj A, Patel GK, et al. Exosomal markers (CD63 and CD9) expression pattern using immunohistochemistry in resected malignant and nonmalignant pancreatic specimens. Pancreas. 2017;46:782–788. doi:10.1097/MPA.0000000000000847
   PubMed Web of Science ®Google Scholar
• Pourhanifeh MH, Mahjoubin‐Tehran M, Shafiee A, et al. MicroRNAs and exosomes: small molecules with big actions in multiple myeloma pathogenesis. IUBMB Life. 2020;72:314–333. doi:10.1002/iub.2211
   PubMed Web of Science ®Google Scholar
• Gai C, Camussi F, Broccoletti R, et al. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma. BMC Cancer. 2018;18:439. doi:10.1186/s12885-018-4364-z
   PubMed Web of Science ®Google Scholar
• Abak A, Abhari A, Rahimzadeh S. Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics. PeerJ. 2018;6:e4763. doi:10.7717/peerj.4763
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–383. doi:10.1083/jcb.201211138
   PubMed Web of Science ®Google Scholar
• Sohn W, Kim J, Kang SH, et al. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Exp Mol Med. 2015;47:e184. doi:10.1038/emm.2015.68
   PubMed Web of Science ®Google Scholar
• Wang H, Hou L, Li A, et al. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int. 2014;2014:864894. doi:10.1155/2014/864894
   PubMed Web of Science ®Google Scholar
• Pluchino S, Smith JA. Explicating exosomes: reclassifying the rising stars of intercellular communication. Cell. 2019;177:225–227. doi:10.1016/j.cell.2019.03.020
   PubMed Web of Science ®Google Scholar
• Mathieu M, Martin-Jaular L, Lavieu G, Thery C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21:9–17. doi:10.1038/s41556-018-0250-9
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–659. doi:10.1038/ncb1596
   PubMed Web of Science ®Google Scholar
• Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13:17–24. doi:10.1016/j.gpb.2015.02.001
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Tumor-derived exosomes and their role in tumor-induced immune suppression. Vaccines. 2016;4:35. doi:10.3390/vaccines4040035
   Web of Science ®Google Scholar
• Ning Y, Shen K, Wu Q, et al. Tumor exosomes block dendritic cells maturation to decrease the T cell immune response. Immunol Lett. 2018;199:36–43. doi:10.1016/j.imlet.2018.05.002
   PubMed Web of Science ®Google Scholar
• Poggio M, Hu T, Pai -C-C, et al. Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell. 2019;177:414–427.e413. doi:10.1016/j.cell.2019.02.016
   PubMed Web of Science ®Google Scholar
• Yu W, Hurley J, Roberts D, et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann Oncol. 2021;32:466–477. doi:10.1016/j.annonc.2021.01.074
   PubMed Web of Science ®Google Scholar
• Nolte-’t Hoen EN, Buermans HPJ, Waasdorp M, et al. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res. 2012;40:9272–9285. doi:10.1093/nar/gks658
   PubMed Web of Science ®Google Scholar
• Ayyar KK, Moss AC. Exosomes in intestinal inflammation. Front Pharmacol. 2021;12:658505. doi:10.3389/fphar.2021.658505
   PubMed Web of Science ®Google Scholar
• Surman M, Drożdż A, Stępień E, Przybyło M. Extracellular vesicles as drug delivery systems - methods of production and potential therapeutic applications. Curr Pharm Des. 2019;25:132–154. doi:10.2174/1381612825666190306153318
   PubMed Web of Science ®Google Scholar
• de Jong OG, Kooijmans SAA, Murphy DE, et al. Drug delivery with extracellular vesicles: from imagination to innovation. Acc Chem Res. 2019;52:1761–1770. doi:10.1021/acs.accounts.9b00109
   PubMed Web of Science ®Google Scholar
• Zlotogorski-Hurvitz A, Dayan D, Chaushu G, Salo T, Vered M. Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals. J Cancer Res Clin Oncol. 2016;142:101–110. doi:10.1007/s00432-015-2005-3
   PubMed Web of Science ®Google Scholar
• Teng F, Fussenegger M. Shedding light on extracellular vesicle biogenesis and bioengineering. Adv Sci. 2020;8:2003505. doi:10.1002/advs.202003505
   Web of Science ®Google Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev. 2002;2:569–579. doi:10.1038/nri855
   Google Scholar
• Batista BS, Eng WS, Pilobello KT, Hendricks-Muñoz KD, Mahal LK. Identification of a conserved glycan signature for microvesicles. J Proteome Res. 2011;10:4624–4633. doi:10.1021/pr200434y
   PubMed Web of Science ®Google Scholar
• Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94:3791–3799. doi:10.1182/blood.V94.11.3791
   PubMed Web of Science ®Google Scholar
• Abels ER, Breakefield XO. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol. 2016;36:301–312. doi:10.1007/s10571-016-0366-z
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev. 2018;19:213–228. doi:10.1038/nrm.2017.125
   Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367. doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Żbikowski A, Błachnio-Zabielska A, Galli M, Zabielski P. Adipose-derived exosomes as possible players in the development of insulin resistance. Int J Mol Sci. 2021;22:7427. doi:10.3390/ijms22147427
   PubMed Web of Science ®Google Scholar
• Bebelman MP, Smit MJ, Pegtel DM, Baglio SR. Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther. 2018;188:1–11. doi:10.1016/j.pharmthera.2018.02.013
   PubMed Web of Science ®Google Scholar
• Ciardiello C, Cavallini L, Spinelli C, et al. Focus on extracellular vesicles: new frontiers of cell-to-cell communication in cancer. Int J Mol Sci. 2016;17:175. doi:10.3390/ijms17020175
   PubMed Web of Science ®Google Scholar
• Johnstone RM. Revisiting the road to the discovery of exosomes. Blood Cells Mol Dis. 2005;34:214–219. doi:10.1016/j.bcmd.2005.03.002
   PubMed Web of Science ®Google Scholar
• Lasser C, Eldh M, Lotvall J. Isolation and characterization of RNA-containing exosomes. JoVE. 2012;e3037. doi:10.3791/3037
   Google Scholar
• Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives. Proteomics. 2008;8:4083–4099. doi:10.1002/pmic.200800109
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8:307. doi:10.3390/cells8040307
   PubMed Web of Science ®Google Scholar
• Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44:2060–2064. doi:10.1016/j.biocel.2012.08.007
   PubMed Web of Science ®Google Scholar
• Fleming A, Sampey G, Chung M-C, et al. The carrying pigeons of the cell: exosomes and their role in infectious diseases caused by human pathogens. Pathog Dis. 2014;71:109–120. doi:10.1111/2049-632X.12135
   PubMed Web of Science ®Google Scholar
• Gon Y, Shimizu T, Mizumura K, Maruoka S, Hikichi M. Molecular techniques for respiratory diseases: microRNA and extracellular vesicles. Respirology. 2020;25:149–160. doi:10.1111/resp.13756
   PubMed Web of Science ®Google Scholar
• Sasaki R, Kanda T, Yokosuka O, et al. Exosomes and hepatocellular carcinoma: from bench to bedside. Int J Mol Sci. 2019;20:1406. doi:10.3390/ijms20061406
   PubMed Web of Science ®Google Scholar
• Kimura K, Hohjoh H, Fukuoka M, et al. Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis. Nat Commun. 2018;9:17. doi:10.1038/s41467-017-02406-2
   PubMed Web of Science ®Google Scholar
• Lu Y, Zheng Z, Yuan Y, et al. The emerging role of exosomes in oral squamous cell carcinoma. Front Cell Dev Biol. 2021;9:628103. doi:10.3389/fcell.2021.628103
   PubMed Web of Science ®Google Scholar
• Liu Y, Cao X. The origin and function of tumor-associated macrophages. Cell Mol Immunol. 2015;12:1–4. doi:10.1038/cmi.2014.83
   PubMed Web of Science ®Google Scholar
• Rhee I. Diverse macrophages polarization in tumor microenvironment. Arch Pharm Res. 2016;39:1588–1596. doi:10.1007/s12272-016-0820-y
   PubMed Web of Science ®Google Scholar
• Zhan C, Yang X, Yin X, Hou J. Exosomes and other extracellular vesicles in oral and salivary gland cancers. Oral Dis. 2020;26:865–875. doi:10.1111/odi.13172
   PubMed Web of Science ®Google Scholar
• You Y, Tian Z, Du Z, et al. M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop. J Exp Clin Cancer Res. 2022;41:10. doi:10.1186/s13046-021-02222-z
   PubMed Web of Science ®Google Scholar
• Pang X, Wang S, Zhang M, et al. Correction to: OSCC cell‑secreted exosomal CMTM6 induced M2‑like macrophages polarization via ERK1/2 signaling pathway. Cancer Immunol Immunother. 2022;71:505–506. doi:10.1007/s00262-021-03113-0
   PubMed Web of Science ®Google Scholar
• Jian, Y, Li, L, Wei-Dong T. Evaluation of isolation and identification methods of exosomes from different biofluids. 2021.
   Google Scholar
• Gardiner C, Vizio DD, Sahoo S, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5:32945. doi:10.3402/jev.v5.32945
   PubMed Web of Science ®Google Scholar
• Helwa I, Cai J, Drewry MD, et al. A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS One. 2017;12(1):e0170628. doi:10.1371/journal.pone.0170628
   PubMed Web of Science ®Google Scholar
• Mol EA, Goumans MJ, Doevendans PA, Sluijter JPG, Vader P. Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation. Nanomedicine. 2017;13:2061–2065. doi:10.1016/j.nano.2017.03.011
   PubMed Web of Science ®Google Scholar
• Tian Y, Gong M, Hu Y, et al. Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry. J Extracell Vesicles. 2020;9:1697028. doi:10.1080/20013078.2019.1697028
   PubMed Web of Science ®Google Scholar
• Gamez-Valero A, Monguió-Tortajada M, Carreras-Planella L, et al. Size-Exclusion Chromatography-based isolation minimally alters Extracellular Vesicles’ characteristics compared to precipitating agents. Sci Rep. 2016;6:33641. doi:10.1038/srep33641
   PubMed Web of Science ®Google Scholar
• Duong P, Chung A, Bouchareychas L, Raffai RL. Cushioned-Density Gradient Ultracentrifugation (C-DGUC) improves the isolation efficiency of extracellular vesicles. PLoS One. 2019;14:e0215324. doi:10.1371/journal.pone.0215324
   PubMed Web of Science ®Google Scholar
• Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7:789–804. doi:10.7150/thno.18133
   PubMed Web of Science ®Google Scholar
• Szatanek R, Baj-Krzyworzeka M, Zimoch J, et al. The methods of choice for Extracellular Vesicles (EVs) characterization. Int J Mol Sci. 2017;18:1153. doi:10.3390/ijms18061153
   PubMed Web of Science ®Google Scholar
• Monguio-Tortajada M, Galvez-Monton C, Bayes-Genis A, Roura S, Borras FE. Extracellular vesicle isolation methods: rising impact of size-exclusion chromatography. Cell Mol Life Sci. 2019;76:2369–2382. doi:10.1007/s00018-019-03071-y
   PubMed Web of Science ®Google Scholar
• Nolan JP, Duggan E. Analysis of individual extracellular vesicles by flow cytometry. Methods Mol Biol. 2018;1678:79–92. doi:10.1007/978-1-4939-7346-0_5
   PubMedGoogle Scholar
• Barros FM, Carneiro F, Machado JC, Melo SA. Exosomes and immune response in cancer: friends or foes? Front Immunol. 2018;9:730. doi:10.3389/fimmu.2018.00730
   PubMed Web of Science ®Google Scholar
• Wang J, Hendrix A, Hernot S, et al. Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells. Blood. 2014;124:555–566. doi:10.1182/blood-2014-03-562439
   PubMed Web of Science ®Google Scholar
• Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer. 2009;9:285–293. doi:10.1038/nrc2621
   PubMed Web of Science ®Google Scholar
• Jiang E, Xu Z, Wang M, et al. Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma. FASEB J. 2019;33:5690–5703. doi:10.1096/fj.201802226R
   PubMed Web of Science ®Google Scholar
• Liu Y, Gu Y, Han Y, et al. Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils. Cancer Cell. 2016;30:243–256. doi:10.1016/j.ccell.2016.06.021
   PubMed Web of Science ®Google Scholar
• Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011;21:139–146. doi:10.1016/j.semcancer.2011.01.002
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289. doi:10.1146/annurev-cellbio-101512-122326
   PubMed Web of Science ®Google Scholar
• Yu S, Cao H, Shen B, Feng J. Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget. 2015;6:37151–37168. doi:10.18632/oncotarget.6022
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233. doi:10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Langevin S, Kuhnell D, Parry T, et al. Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells in vitro reveals common secretion profiles and potential utility as salivary biomarkers. Oncotarget. 2017;8:82459–82474. doi:10.18632/oncotarget.19614
   PubMedGoogle Scholar
• He L, Ping F, Fan Z, et al. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening. Biomed Pharmacother. 2020;121:109553. doi:10.1016/j.biopha.2019.109553
   PubMed Web of Science ®Google Scholar
• Sharma S, Gillespie BM, Palanisamy V, Gimzewski JK. Quantitative nanostructural and single-molecule force spectroscopy biomolecular analysis of human-saliva-derived exosomes. Langmuir. 2011;27:14394–14400. doi:10.1021/la2038763
   PubMed Web of Science ®Google Scholar
• Cui J, Wang H, Zhang X, et al. Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B. Aging. 2020;12:6756–6773. doi:10.18632/aging.103036
   PubMedGoogle Scholar
• Xiao M, Zhang J, Chen W, Chen W. M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma. J Exp Clin Cancer Res. 2018;37:143. doi:10.1186/s13046-018-0815-2
   PubMed Web of Science ®Google Scholar
• Cai J, Qiao B, Gao N, Lin N, He W. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p. Cell Physiol. 2019;316:C731–c740. doi:10.1152/ajpcell.00366.2018
   PubMed Web of Science ®Google Scholar
• Mori K, Hiroi M, Shimada J, Ohmori Y. Infiltration of m2 tumor-associated macrophages in oral squamous cell carcinoma correlates with tumor malignancy. Cancers. 2011;3:3726–3739. doi:10.3390/cancers3043726
   PubMedGoogle Scholar
• Pang X, Wang -S-S, Zhang M, et al. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway. Cancer Immunol Immunother. 2021;70:1015–1029. doi:10.1007/s00262-020-02741-2
   PubMed Web of Science ®Google Scholar
• Baig MS, Roy A, Rajpoot S, et al. Tumor-derived exosomes in the regulation of macrophage polarization. Inflamm Res. 2020;69:435–451. doi:10.1007/s00011-020-01318-0
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932–936. doi:10.1038/nature04478
   PubMed Web of Science ®Google Scholar
• He S, Zhang W, Li X, et al. Oral squamous cell carcinoma (OSCC)-derived exosomal MiR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation. Bioengineered. 2021;12:2164–2174. doi:10.1080/21655979.2021.1932222
   PubMed Web of Science ®Google Scholar
• Wang H, Wang L, Zhou X, et al. OSCC exosomes regulate miR-210-3p targeting EFNA3 to promote oral cancer angiogenesis through the PI3K/AKT pathway. Biomed Res Int. 2020;2020:2125656. doi:10.1155/2020/2125656
   PubMed Web of Science ®Google Scholar
• Sakha S, Muramatsu T, Ueda K, Inazawa J. Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci Rep. 2016;6:38750. doi:10.1038/srep38750
   PubMed Web of Science ®Google Scholar
• Kawakubo-Yasukochi T, Morioka M, Hazekawa M, et al. miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment. Mol Carcinog. 2018;57:295–302. doi:10.1002/mc.22744
   PubMed Web of Science ®Google Scholar
• Masyuk AI, Masyuk TV, Larusso NF. Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol. 2013;59:621–625. doi:10.1016/j.jhep.2013.03.028
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhou X, Zhang H, et al. Extracellular vesicles in diagnosis and therapy of kidney diseases. Ren Physiol. 2016;311:F844–f851. doi:10.1152/ajprenal.00429.2016
   Google Scholar
• Alipoor SD, Mortaz E, Garssen J, et al. Exosomes and exosomal miRNA in respiratory diseases. Mediators Inflamm. 2016;2016:5628404. doi:10.1155/2016/5628404
   PubMed Web of Science ®Google Scholar
• Jansen F, Li Q. Exosomes as diagnostic biomarkers in cardiovascular diseases. Adv Exp Med Biol. 2017;998:61–70. doi:10.1007/978-981-10-4397-0_4
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hu YW, Zheng L, Wang Q. Characteristics and roles of exosomes in cardiovascular disease. DNA Cell Biol. 2017;36:202–211. doi:10.1089/dna.2016.3496
   PubMed Web of Science ®Google Scholar
• Kanninen KM, Bister N, Koistinaho J, Malm T. Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta. 2016;1862:403–410. doi:10.1016/j.bbadis.2015.09.020
   PubMed Web of Science ®Google Scholar
• Luo Y, Liu F, Guo J, Gui R. Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC. Sci Rep. 2020;10:13739. doi:10.1038/s41598-020-70747-y
   PubMed Web of Science ®Google Scholar
• Guo H, Jiang W, Huang S, Huang X, Li C. Serum exosome-derived biomarkers for the early detection of oral squamous cell carcinoma. Mol Cell Biochem. 2021;476:4435–4447. doi:10.1007/s11010-021-04254-7
   PubMed Web of Science ®Google Scholar
• Martinez P, Birkbak NJ, Gerlinger M, et al. Parallel evolution of tumour subclones mimics diversity between tumours. J Pathol. 2013;230:356–364. doi:10.1002/path.4214
   PubMed Web of Science ®Google Scholar
• Oxnard GR, Paweletz CP, Sholl LM. Genomic analysis of plasma cell-free DNA in patients with cancer. JAMA Oncol. 2017;3:740–741. doi:10.1001/jamaoncol.2016.2835
   PubMed Web of Science ®Google Scholar
• Tadimety A, Closson A, Li C, et al. Advances in liquid biopsy on-chip for cancer management: technologies, biomarkers, and clinical analysis. Crit Rev Clin Lab Sci. 2018;55:140–162. doi:10.1080/10408363.2018.1425976
   PubMed Web of Science ®Google Scholar
• Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10:472–484. doi:10.1038/nrclinonc.2013.110
   PubMed Web of Science ®Google Scholar
• Balasaheb Mali S, Dahivelkar S. Liquid biopsy = Individualized cancer management: diagnosis, monitoring treatment and checking recurrence and metastasis. Oral Oncol. 2021;123:105588. doi:10.1016/j.oraloncology.2021.105588
   PubMed Web of Science ®Google Scholar
• Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent. 2009;22:241–248.
   PubMed Web of Science ®Google Scholar
• Sas R, Dawes C. The intra-oral distribution of unstimulated and chewing-gum-stimulated parotid saliva. Arch Oral Biol. 1997;42:469–474. doi:10.1016/s0003-9969(97)00045-9
   PubMed Web of Science ®Google Scholar
• Sun QF, Sun QH, Du J, Wang S. Differential gene expression profiles of normal human parotid and submandibular glands. Oral Dis. 2008;14:500–509. doi:10.1111/j.1601-0825.2007.01408.x
   PubMed Web of Science ®Google Scholar
• Deutsch O, Fleissig Y, Zaks B, et al. An approach to remove alpha amylase for proteomic analysis of low abundance biomarkers in human saliva. Electrophoresis. 2008;29:4150–4157. doi:10.1002/elps.200800207
   PubMed Web of Science ®Google Scholar
• Han Y, Jia L, Zheng Y, Li W. Salivary exosomes: emerging roles in systemic disease. Int J Biol Sci. 2018;14:633–643. doi:10.7150/ijbs.25018
   PubMed Web of Science ®Google Scholar
• Gonzalez-Begne M, Lu B, Han X, et al. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res. 2009;8:1304–1314. doi:10.1021/pr800658c
   PubMed Web of Science ®Google Scholar
• Principe S, Hui AB-Y, Bruce J, et al. Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery. Proteomics. 2013;13:1608–1623. doi:10.1002/pmic.201200533
   PubMed Web of Science ®Google Scholar
• Li C, Zhou Y, Liu J, et al. Potential markers from serum-purified exosomes for detecting oral squamous cell carcinoma metastasis. Cancer Epidemiol Biomarkers Prev. 2019;28:1668–1681. doi:10.1158/1055-9965.Epi-18-1122
   PubMed Web of Science ®Google Scholar
• Rabinowits G, Bowden M, Flores LM, et al. Comparative analysis of microRNA expression among benign and malignant tongue tissue and plasma of patients with tongue cancer. Front Oncol. 2017;7:191. doi:10.3389/fonc.2017.00191
   PubMed Web of Science ®Google Scholar
• Sedykh S, Kuleshova A, Nevinsky G. Milk exosomes: perspective agents for anticancer drug delivery. Int J Mol Sci. 2020;21:6646. doi:10.3390/ijms21186646
   PubMed Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16:71. doi:10.1186/s12951-018-0392-8
   PubMed Web of Science ®Google Scholar
• Ferreira D, Moreira JN, Rodrigues LR. New advances in exosome-based targeted drug delivery systems. Crit Rev Oncol Hematol. 2022;172:103628. doi:10.1016/j.critrevonc.2022.103628
   PubMed Web of Science ®Google Scholar
• Perez AT, Domenech GH, Frankel C, Vogel CL. Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network, Inc., experience. Cancer Invest. 2002;20:22–29. doi:10.1081/CNV-120014883
   PubMed Web of Science ®Google Scholar
• Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta pharmaceutica Sinica B. 2016;6:287–296. doi:10.1016/j.apsb.2016.02.001
   PubMed Web of Science ®Google Scholar
• Jiang X-C, Gao J-Q. Exosomes as novel bio-carriers for gene and drug delivery. Int J Pharm. 2017;521:167–175. doi:10.1016/j.ijpharm.2017.02.038
   PubMed Web of Science ®Google Scholar
• Bunggulawa EJ, Wang W, Yin T, et al. Recent advancements in the use of exosomes as drug delivery systems. J Nanobiotechnology. 2018;16:81. doi:10.1186/s12951-018-0403-9
   PubMed Web of Science ®Google Scholar
• Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18:1606–1614. doi:10.1038/mt.2010.105
   PubMed Web of Science ®Google Scholar
• Pascucci L, Coccè V, Bonomi A, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release. 2014;192:262–270. doi:10.1016/j.jconrel.2014.07.042
   PubMed Web of Science ®Google Scholar
• Zeelenberg IS, Ostrowski M, Krumeich S, et al. Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. Cancer Res. 2008;68:1228–1235. doi:10.1158/0008-5472.CAN-07-3163
   PubMed Web of Science ®Google Scholar
• Johnsen KB, Gudbergsson JM, Skov MN, et al. Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. Cytotechnology. 2016;68:2125–2138. doi:10.1007/s10616-016-9952-7
   PubMed Web of Science ®Google Scholar
• Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release. 2015;205:35–44. doi:10.1016/j.jconrel.2014.11.029
   PubMed Web of Science ®Google Scholar
• Luan X, Sansanaphongpricha K, Myers I, et al. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38:754–763. doi:10.1038/aps.2017.12
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine. 2016;12:655–664. doi:10.1016/j.nano.2015.10.012
   PubMed Web of Science ®Google Scholar
• Sato YT, Umezaki K, Sawada S, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6:21933. doi:10.1038/srep21933
   PubMed Web of Science ®Google Scholar
• Liao W, Du Y, Zhang C, et al. Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta biomaterialia. 2019;86:1–14. doi:10.1016/j.actbio.2018.12.045
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen Y, Zhang F, Zhao Q, Zhong H. Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress. Int J Hyperthermia. 2015;31:498–506. doi:10.3109/02656736.2015.1036384
   PubMed Web of Science ®Google Scholar
• González-Sarrías A, Iglesias-Aguirre CE, Cortés-Martín A, et al. Milk-derived exosomes as nanocarriers to deliver curcumin and resveratrol in breast tissue and enhance their anticancer activity. Int J Mol Sci. 2022;23:2860. doi:10.3390/ijms23052860
   PubMed Web of Science ®Google Scholar
• Yim N, Ryu S-W, Choi K, et al. Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. Nat Commun. 2016;7:12277. doi:10.1038/ncomms12277
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang H, Ning T, et al. Exosome-delivered c-Met siRNA could reverse chemoresistance to cisplatin in gastric cancer. Int J Nanomedicine. 2020;15:2323–2335. doi:10.2147/IJN.S231214
   PubMed Web of Science ®Google Scholar
• Wang J, Li G, Tu C, et al. High-throughput single-cell analysis of exosome mediated dual drug delivery, in vivo fate and synergistic tumor therapy. Nanoscale. 2020;12:13742–13756. doi:10.1039/d0nr02344b
   PubMed Web of Science ®Google Scholar
• Meng QF, Zhao Y, Dong C, et al. Genetically programmable fusion cellular vesicles for cancer immunotherapy. Angewandte Chemie. 2021. doi:10.1002/anie.202108342
   Google Scholar
• Mendt M, Kamerkar S, Sugimoto H, et al. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018;3. doi:10.1172/jci.insight.99263
   PubMed Web of Science ®Google Scholar
• Zhu X, Badawi M, Pomeroy S, et al. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J Extracell Vesicles. 2017;6:1324730. doi:10.1080/20013078.2017.1324730
   PubMed Web of Science ®Google Scholar
• Kordelas L, Rebmann V, Ludwig A-K, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28:970–973. doi:10.1038/leu.2014.41
   PubMed Web of Science ®Google Scholar
• Kandimalla R, Aqil F, Alhakeem SS, et al. Targeted oral delivery of paclitaxel using colostrum-derived exosomes. Cancers. 2021;13:3700. doi:10.3390/cancers13153700
   PubMed Web of Science ®Google Scholar
• Li L, Lu S, Liang X, et al. gammadeltaTDEs: an efficient delivery system for miR-138 with anti-tumoral and immunostimulatory roles on oral squamous cell carcinoma. Mol Ther Nucleic Acids. 2019;14:101–113. doi:10.1016/j.omtn.2018.11.009
   PubMedGoogle Scholar
• Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15:563–568. doi:10.1016/j.gde.2005.08.005
   PubMed Web of Science ®Google Scholar
• Wang Z, Yan J, Zou T, Gao H. MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc. Oncol Lett. 2018;16:2243–2250. doi:10.3892/ol.2018.8967
   PubMed Web of Science ®Google Scholar
• Higaki M, Shintani T, Hamada A, Rosli SNZ, Okamoto T. Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1). In vitro cellular & developmental biology. Animal. 2020;56:222–233. doi:10.1007/s11626-020-00440-x
   Web of Science ®Google Scholar
• Xie C, Du LY, Guo F, Li X, Cheng B. Exosomes derived from microRNA-101-3p-overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration. Mol Cell Biochem. 2019;458:11–26. doi:10.1007/s11010-019-03526-7
   PubMed Web of Science ®Google Scholar
• Chan M-H, Chang Z-X, Huang C-YF, et al. Integrated therapy platform of exosomal system: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment. Nanoscale Horiz. 2022;7:352–367. doi:10.1039/d1nh00637a
   PubMed Web of Science ®Google Scholar
• Wu D, Kang L, Tian J, et al. Exosomes derived from bone mesenchymal stem cells with the stimulation of FeO nanoparticles and static magnetic field enhance wound healing through upregulated miR-21-5p. Int J Nanomedicine. 2020;15:7979–7993. doi:10.2147/IJN.S275650
   PubMed Web of Science ®Google Scholar
• Yang L, Patel KD, Rathnam C, et al. Harnessing the therapeutic potential of extracellular vesicles for biomedical applications using multifunctional magnetic nanomaterials. Small. 2022;18:e2104783. doi:10.1002/smll.202104783
   PubMed Web of Science ®Google Scholar
• Chen Y, Hou S. Application of magnetic nanoparticles in cell therapy. Stem Cell Res Ther. 2022;13:135. doi:10.1186/s13287-022-02808-0
   PubMed Web of Science ®Google Scholar
• Vallina C, López-Pintor RM, González-Serrano J, et al. Genes involved in the epithelial-mesenchymal transition in oral cancer: a systematic review. Oral Oncol. 2021;117:105310. doi:10.1016/j.oraloncology.2021.105310
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Eguchi T, Sogawa C, et al. Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab. Oral Oncol. 2018;86:251–257. doi:10.1016/j.oraloncology.2018.09.030
   PubMed Web of Science ®Google Scholar
• Zhang H, Deng T, Ge S, et al. Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7. Oncogene. 2019;38:2844–2859. doi:10.1038/s41388-018-0619-z
   PubMed Web of Science ®Google Scholar
• Liu T, Chen G, Sun D, et al. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai). 2017;49:808–816. doi:10.1093/abbs/gmx078
   PubMed Web of Science ®Google Scholar
• Li L, Li C, Wang S, et al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res. 2016;76:1770–1780. doi:10.1158/0008-5472.Can-15-1625
   PubMed Web of Science ®Google Scholar
• Tomita R, Sasabe E, Tomomura A, Yamamoto T. Macrophage‑derived exosomes attenuate the susceptibility of oral squamous cell carcinoma cells to chemotherapeutic drugs through the AKT/GSK‑3β pathway. Oncol Rep. 2020. doi:10.3892/or.2020.7748
   PubMed Web of Science ®Google Scholar
• Zhang B, Yin Y, Lai RC, Lim SK. Immunotherapeutic potential of extracellular vesicles. Front Immunol. 2014;5:518. doi:10.3389/fimmu.2014.00518
   PubMed Web of Science ®Google Scholar
• Li XB, Zhang ZR, Schluesener HJ, Xu SQ. Role of exosomes in immune regulation. J Cell Mol Med. 2006;10:364–375. doi:10.1111/j.1582-4934.2006.tb00405.x
   PubMed Web of Science ®Google Scholar
• Tekiki N, Fujita M, Okui T, et al. Dynamic contrast-enhanced MRI as a predictor of programmed death ligand-1 expression in patients with oral squamous cell carcinoma. Oncol Lett. 2021;22:778. doi:10.3892/ol.2021.13039
   PubMed Web of Science ®Google Scholar
• Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27:450–461. doi:10.1016/j.ccell.2015.03.001
   PubMed Web of Science ®Google Scholar
• Brahmer JR, Drake CG, Wollner I, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010;28:3167–3175. doi:10.1200/JCO.2009.26.7609
   PubMed Web of Science ®Google Scholar
• Kandoth C, McLellan MD, Vandin F, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502:333–339. doi:10.1038/nature12634
   PubMed Web of Science ®Google Scholar
• Wang Y, Qin X, Zhu X, et al. Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway. Oral Oncol. 2018;76:34–41. doi:10.1016/j.oraloncology.2017.11.024
   PubMed Web of Science ®Google Scholar
• Ding L, Ren J, Zhang D, et al. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33. Carcinogenesis. 2018;39:397–406. doi:10.1093/carcin/bgy006
   PubMed Web of Science ®Google Scholar
• Yang E, Wang X, Gong Z, et al. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Ther. 2020;5:242. doi:10.1038/s41392-020-00359-5
   PubMed Web of Science ®Google Scholar
• Wendler F, Favicchio R, Simon T, et al. Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention. Oncogene. 2017;36:877–884. doi:10.1038/onc.2016.253
   PubMed Web of Science ®Google Scholar
• Sento S, Sasabe E, Yamamoto T, Tang C-H. Application of a persistent heparin treatment inhibits the malignant potential of oral squamous carcinoma cells induced by tumor cell-derived exosomes. PLoS One. 2016;11:e0148454. doi:10.1371/journal.pone.0148454
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Trachtenberg AJ, Kuo WP, Cheng YS. Genomewide study of salivary microRNAs for detection of oral cancer. J Dent Res. 2014;93:86s–93s. doi:10.1177/0022034514531018
   PubMed Web of Science ®Google Scholar
• Zahran F, Ghalwash D, Shaker O, Al-Johani K, Scully C. Salivary microRNAs in oral cancer. Oral Dis. 2015;21:739–747. doi:10.1111/odi.12340
   PubMed Web of Science ®Google Scholar
• Cai J, Han Y, Ren H, et al. Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol. 2013;5:227–238. doi:10.1093/jmcb/mjt011
   PubMed Web of Science ®Google Scholar
• Kahlert C, Melo SA, Protopopov A, et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem. 2014;289:3869–3875. doi:10.1074/jbc.C113.532267
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. Discovery of double-stranded genomic DNA in circulating exosomes. Cold Spring Harb Symp Quant Biol. 2016;81:275–280. doi:10.1101/sqb.2016.81.030932
   PubMedGoogle Scholar
• Thakur BK, Zhang H, Becker A, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24:766–769. doi:10.1038/cr.2014.44
   PubMed Web of Science ®Google Scholar
• Salehi M, Sharifi M. Exosomal miRNAs as novel cancer biomarkers: challenges and opportunities. J Cell Physiol. 2018;233:6370–6380. doi:10.1002/jcp.26481
   PubMed Web of Science ®Google Scholar
• Alhasan AH, Scott AW, Wu JJ, et al. Circulating microRNA signature for the diagnosis of very high-risk prostate cancer. Proc Natl Acad Sci USA. 2016;113:10655–10660. doi:10.1073/pnas.1611596113
   PubMed Web of Science ®Google Scholar
• Halvaei S, Daryani S, Eslami-S Z, et al. Exosomes in cancer liquid biopsy: a focus on breast cancer. Mol Ther. 2018;10:131–141. doi:10.1016/j.omtn.2017.11.014
   Web of Science ®Google Scholar
• Stevic I, Müller V, Weber K, et al. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial. BMC Med. 2018;16:179. doi:10.1186/s12916-018-1163-y
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhu W, Li H, et al. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis. Sci Rep. 2015;5:11251. doi:10.1038/srep11251
   PubMed Web of Science ®Google Scholar
• Thind A, Wilson C. Exosomal miRNAs as cancer biomarkers and therapeutic targets. J Extracell Vesicles. 2016;5:31292. doi:10.3402/jev.v5.31292
   PubMed Web of Science ®Google Scholar
• Castillo J, Bernard V, San Lucas FA, et al. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol. 2018;29:223–229. doi:10.1093/annonc/mdx542
   PubMed Web of Science ®Google Scholar
• Yoshioka Y, Kosaka N, Konishi Y, et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun. 2014;5:3591. doi:10.1038/ncomms4591
   PubMed Web of Science ®Google Scholar
• Sharma R, Huang X, Brekken RA, Schroit AJ. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies. Br J Cancer. 2017;117:545–552. doi:10.1038/bjc.2017.183
   PubMed Web of Science ®Google Scholar
• Wang A, Liu J, Zhuang X, et al. Identification and comparison of piRNA expression profiles of exosomes derived from human stem cells from the apical papilla and bone marrow mesenchymal stem cells. Stem Cells Dev. 2020;29:511–520. doi:10.1089/scd.2019.0277
   PubMed Web of Science ®Google Scholar
• Arrighetti N, Corbo C, Evangelopoulos M, et al. Exosome-like nanovectors for drug delivery in cancer. Curr Med Chem. 2019;26:6132–6148. doi:10.2174/0929867325666180831150259
   PubMed Web of Science ®Google Scholar
• Pullan JE, Confeld MI, Osborn JK, et al. Exosomes as drug carriers for cancer therapy. Mol Pharm. 2019;16:1789–1798. doi:10.1021/acs.molpharmaceut.9b00104
   PubMed Web of Science ®Google Scholar
• Butreddy A, Kommineni N, Dudhipala N. Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives. Nanomaterials. 2021;11:1481. doi:10.3390/nano11061481
   Web of Science ®Google Scholar
• Yeo RW, Lai RC, Zhang B, et al. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev. 2013;65:336–341. doi:10.1016/j.addr.2012.07.001
   PubMed Web of Science ®Google Scholar
• Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498–503. doi:10.1038/nature22341
   PubMed Web of Science ®Google Scholar
• Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles. 2014;3:23743. doi:10.3402/jev.v3.23743
   PubMedGoogle Scholar
• Hu Y, Zhang R, Chen G. Exosome and secretion: action on? Adv Exp Med Biol. 2020;1248:455–483. doi:10.1007/978-981-15-3266-5_19
   PubMed Web of Science ®Google Scholar
• Wang Q, Lv L, Li Y, Ji H. MicroRNA‑655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway. Mol Med Rep. 2018;18:3106–3114. doi:10.3892/mmr.2018.9292
   PubMed Web of Science ®Google Scholar
• Katakowski M, Buller B, Zheng X, et al. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett. 2013;335:201–204. doi:10.1016/j.canlet.2013.02.019
   PubMed Web of Science ®Google Scholar
• Ohno S, Takanashi M, Sudo K, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013;21:185–191. doi:10.1038/mt.2012.180
   PubMed Web of Science ®Google Scholar
• Tran PHL, Xiang D, Tran TTD, et al. Exosomes and nanoengineering: a match made for precision therapeutics. Adv Mater. 2020;32:e1904040. doi:10.1002/adma.201904040
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomedicine. 2018;14:195–204. doi:10.1016/j.nano.2017.09.011
   PubMed Web of Science ®Google Scholar
• Ruckman J, Green LS, Beeson J, et al. 2’-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem. 1998;273:20556–20567. doi:10.1074/jbc.273.32.20556
   PubMed Web of Science ®Google Scholar
• Zhao C, Busch DJ, Vershel CP, Stachowiak JC. Multifunctional transmembrane protein ligands for cell-specific targeting of plasma membrane-derived vesicles. Small. 2016;12:3837–3848. doi:10.1002/smll.201600493
   PubMed Web of Science ®Google Scholar
• Zhou G, Latchoumanin O, Hebbard L, et al. Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers. Adv Drug Deliv Rev. 2018;134:107–121. doi:10.1016/j.addr.2018.04.005
   PubMed Web of Science ®Google Scholar
• Gefen T, Castro I, Muharemagic D, et al. A TIM-3 oligonucleotide aptamer enhances T cell functions and potentiates tumor immunity in mice. Mol Ther. 2017;25:2280–2288. doi:10.1016/j.ymthe.2017.06.023
   PubMed Web of Science ®Google Scholar
• Zhou J, Rossi J. Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discov. 2017;16:181–202. doi:10.1038/nrd.2016.199
   PubMed Web of Science ®Google Scholar
• Rahimizadeh K, AlShamaileh H, Fratini M, et al. Development of cell-specific aptamers: recent advances and insight into the selection procedures. Molecules. 2017;22:2070. doi:10.3390/molecules22122070
   PubMed Web of Science ®Google Scholar
• Dai S, Wei D, Wu Z, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16:782–790. doi:10.1038/mt.2008.1
   PubMed Web of Science ®Google Scholar
• Escudier B, Dorval T, Chaput N, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med. 2005;3:10. doi:10.1186/1479-5876-3-10
   PubMed Web of Science ®Google Scholar
• Wan M, Ning B, Spiegel S, Lyon CJ, Hu TY. Tumor-derived exosomes (TDEs): how to avoid the sting in the tail. Med Res Rev. 2020;40:385–412. doi:10.1002/med.21623
   PubMed Web of Science ®Google Scholar
• Taylor DD, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 2015;87:3–10. doi:10.1016/j.ymeth.2015.02.019
   PubMed Web of Science ®Google Scholar
• Liu W, Li J, Wu Y, et al. Target-induced proximity ligation triggers recombinase polymerase amplification and transcription-mediated amplification to detect tumor-derived exosomes in nasopharyngeal carcinoma with high sensitivity. Biosens Bioelectron. 2018;102:204–210. doi:10.1016/j.bios.2017.11.033
   PubMed Web of Science ®Google Scholar
• Xing S, Lu Z, Huang Q, et al. An ultrasensitive hybridization chain reaction-amplified CRISPR-Cas12a aptasensor for extracellular vesicle surface protein quantification. Theranostics. 2020;10:10262–10273. doi:10.7150/thno.49047
   PubMed Web of Science ®Google Scholar
• Liu C, Xu X, Li B, et al. Single-exosome-counting immunoassays for cancer diagnostics. Nano Lett. 2018;18:4226–4232. doi:10.1021/acs.nanolett.8b01184
   PubMed Web of Science ®Google Scholar
• Ketabat F, Pundir M, Mohabatpour F, et al. Controlled drug delivery systems for oral cancer treatment-current status and future perspectives. Pharmaceutics. 2019;11:302. doi:10.3390/pharmaceutics11070302
   PubMed Web of Science ®Google Scholar
• Stremersch S, De Smedt SC, Raemdonck K. Therapeutic and diagnostic applications of extracellular vesicles. J Control Release. 2016;244:167–183. doi:10.1016/j.jconrel.2016.07.054
   PubMed Web of Science ®Google Scholar
• Chen T, Guo J, Yang M, Zhu X, Cao X. Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol. 2011;186:2219–2228. doi:10.4049/jimmunol.1002991
   PubMed Web of Science ®Google Scholar
• McKiernan J, Donovan MJ, O’Neill V, et al. A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy. JAMA Oncol. 2016;2:882–889. doi:10.1001/jamaoncol.2016.0097
   PubMed Web of Science ®Google Scholar
• McKiernan J, Donovan MJ, Margolis E, et al. A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients with prostate-specific antigen 2–10 ng/mL at initial biopsy. Eur Urol. 2018;74:731–738. doi:10.1016/j.eururo.2018.08.019
   PubMed Web of Science ®Google Scholar